Literature DB >> 26019708

Static image analysis as new approach for the characterization of tumor cell lysate used in dendritic cell vaccine preparation.

Isabelle Müller1, Dorothee Hartmann1, Joachim Oertel2, Cornelia M Keck3, Hermann Eichler1.   

Abstract

BACKGROUND: Safety is an important consideration for the clinical application of dendritic cells (DC) loaded with autologous tumor lysate (TL). Thus, avitalization of TL from living autologous tumor tissue has to be guaranteed.
METHODS: Composition of TL was investigated by static image analysis (SIA) with the Morphologi G3 device, which simultaneously measures size and shape of up to 100,000 particles within one sample run. This approach was compared with sample characterization by high-resolution automated cell counting, trypan blue staining, and ATP quantification.
RESULTS: Using SIA, we only detected fragmented, non-cellular structures in completely avitalized TL, indicating complete destruction of living cells. Analysis of particle size distribution by SIA as well as CASY cell counter showed that 95% of particles had a diameter of <10 µm as a sign of cell fragmentation. Complete avitalization of TL was confirmed with trypan blue staining and ATP analysis.
CONCLUSION: Regarding generation of DC vaccines, the proof of avitality of TL from living tumor tissue can clearly be achieved by SIA alone or in combination with standard assays. Our data show that SIA is a highly precise method for TL characterization. The SIA device complies with FDA regulation and, therefore, might be suitable for characterization of cellular therapy medicinal products.

Entities:  

Keywords:  Autologous tumor lysate; Avitality; Bioinactivity; DC vaccine

Year:  2015        PMID: 26019708      PMCID: PMC4439780          DOI: 10.1159/000371480

Source DB:  PubMed          Journal:  Transfus Med Hemother        ISSN: 1660-3796            Impact factor:   3.747


  22 in total

Review 1.  Hide-and-seek in the brain: a role for HLA-G mediating immune privilege for glioma cells.

Authors:  Heinz Wiendl; Meike Mitsdoerffer; Michael Weller
Journal:  Semin Cancer Biol       Date:  2003-10       Impact factor: 15.707

2.  Multiple-laboratory comparison of in vitro assays utilized to characterize hematopoietic cells in cord blood.

Authors:  Gary Moroff; Hermann Eichler; Anneke Brand; Riitta Kekomäki; James Kurtz; Magdalena Letowska; Derwood Pamphilon; Elizabeth J Read; Laura Porretti; Lucilla Lecchi; Jo-Anna Reems; Ronald Sacher; Shalini Seetharaman; Tsuneo A Takahashi
Journal:  Transfusion       Date:  2006-04       Impact factor: 3.157

3.  An evaluation of the in vitro cytotoxicities of 50 chemicals by using an electrical current exclusion method versus the neutral red uptake and MTT assays.

Authors:  Toni Lindl; Birgit Lewandowski; Sonya Schreyögg; Andrea Stäudte
Journal:  Altern Lab Anim       Date:  2005-12       Impact factor: 1.303

4.  Viability does not necessarily reflect the hematopoietic progenitor cell potency of a cord blood unit: results of an interlaboratory exercise.

Authors:  Anneke Brand; Hermann Eichler; Zbigniew M Szczepiorkowski; John R Hess; Riitta Kekomaki; David H McKenna; Derwood Pamphilon; Joanna Reems; Ronald A Sacher; Tsuneo A Takahashi; Leo M G van de Watering
Journal:  Transfusion       Date:  2007-12-07       Impact factor: 3.157

Review 5.  Machine learning in cell biology - teaching computers to recognize phenotypes.

Authors:  Christoph Sommer; Daniel W Gerlich
Journal:  J Cell Sci       Date:  2013-11-20       Impact factor: 5.285

6.  Vaccination of malignant glioma patients with peptide-pulsed dendritic cells elicits systemic cytotoxicity and intracranial T-cell infiltration.

Authors:  J S Yu; C J Wheeler; P M Zeltzer; H Ying; D N Finger; P K Lee; W H Yong; F Incardona; R C Thompson; M S Riedinger; W Zhang; R M Prins; K L Black
Journal:  Cancer Res       Date:  2001-02-01       Impact factor: 12.701

7.  Treatment of non-resectable hepatocellular carcinoma with autologous tumor-pulsed dendritic cells.

Authors:  Andrew Ladhams; Chris Schmidt; Garwin Sing; Lesley Butterworth; George Fielding; Paul Tesar; Russell Strong; Barbara Leggett; Lawrie Powell; Guy Maddern; Kay Ellem; Graham Cooksley
Journal:  J Gastroenterol Hepatol       Date:  2002-08       Impact factor: 4.029

8.  Optimizing parameters for clinical-scale production of high IL-12 secreting dendritic cells pulsed with oxidized whole tumor cell lysate.

Authors:  Cheryl L-L Chiang; Dawn A Maier; Lana E Kandalaft; Andrea L Brennan; Evripidis Lanitis; Qunrui Ye; Bruce L Levine; Brian J Czerniecki; Daniel J Powell; George Coukos
Journal:  J Transl Med       Date:  2011-11-14       Impact factor: 5.531

9.  Phase I trial of a multi-epitope-pulsed dendritic cell vaccine for patients with newly diagnosed glioblastoma.

Authors:  Surasak Phuphanich; Christopher J Wheeler; Jeremy D Rudnick; Mia Mazer; Hongqian Wang; Miriam A Nuño; Jaime E Richardson; Xuemo Fan; Jianfei Ji; Ray M Chu; James G Bender; Elma S Hawkins; Chirag G Patil; Keith L Black; John S Yu
Journal:  Cancer Immunol Immunother       Date:  2012-07-31       Impact factor: 6.968

10.  Sphingosine kinase activity is not required for tumor cell viability.

Authors:  Karen Rex; Shawn Jeffries; Matthew L Brown; Timothy Carlson; Angela Coxon; Flordeliza Fajardo; Brendon Frank; Darin Gustin; Alexander Kamb; Paul D Kassner; Shyun Li; Yihong Li; Kurt Morgenstern; Matthew Plant; Kim Quon; Astrid Ruefli-Brasse; Joanna Schmidt; Elissa Swearingen; Nigel Walker; Zhulun Wang; J E Vivienne Watson; Dineli Wickramasinghe; Mariwil Wong; Guifen Xu; Holger Wesche
Journal:  PLoS One       Date:  2013-07-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.